GeneCapture, Inc.
GeneCapture is dedicated to developing rapid, portable diagnostic platforms for pathogen identification and antimicrobial susceptibility testing. Their innovative solutions aim to provide fast, easy, and accurate results in any environment, supporting healthcare, military, and agricultural applications. Their mission is to significantly reduce the time to diagnose infections, improve treatment outcomes, and combat antimicrobial resistance, with a focus on point-of-care testing and broad-spectrum pathogen detection.
Industries
Nr. of Employees
small (1-50)
GeneCapture, Inc.
Patents
Integrated cartridge for sample homogenization and nucleic acid fragmentation
US-11918996-B2
View Details
Integrated cartridge for sample homogenization and nucleic acid fragmentation
US-11918996-B2
View DetailsProducts
Portable point-of-care pathogen identification and phenotypic AST platform
A low-cost, portable instrument paired with an integrated disposable cartridge that accepts raw samples, performs on-cartridge sample prep, detects pathogens via direct RNA hybridization on a microarray, captures assay images with CMOS imaging, and reports pathogen ID and phenotypic antibiotic susceptibility without laboratory infrastructure.
Portable point-of-care pathogen identification and phenotypic AST platform
A low-cost, portable instrument paired with an integrated disposable cartridge that accepts raw samples, performs on-cartridge sample prep, detects pathogens via direct RNA hybridization on a microarray, captures assay images with CMOS imaging, and reports pathogen ID and phenotypic antibiotic susceptibility without laboratory infrastructure.
Services
Collaborative development, feasibility testing, and demonstration of point-of-care pathogen identification and phenotypic AST under government and research contracts; includes assay development, imaging/AI support, and field-testing preparation.
Collaborative development, feasibility testing, and demonstration of point-of-care pathogen identification and phenotypic AST under government and research contracts; includes assay development, imaging/AI support, and field-testing preparation.
Expertise Areas
- Point-of-care diagnostic development
- Phenotypic antimicrobial susceptibility testing
- Microarray-based nucleic acid detection
- Assay design and probe library development
Key Technologies
- Microarray-based RNA hybridization
- Non-amplified RNA detection
- CMOS imaging
- Image processing and machine learning
News & Updates
$2.5 Million DoD Award
GeneCapture was awarded a $2.5 million contract from the Department of Defense for developing rapid pathogen detection and antibiotic susceptibility testing platform for military and civilian use.
$1 Million DoD Award
GeneCapture received a $1 million award to add invasive fungal pathogen probes to its rapid detection panel, supporting military and civilian health.
Collaboration with Auburn University
GeneCapture announced a collaboration with Auburn University to enable remote infection detection for animal and agricultural applications, supported by a SBIR grant.
National DoD Award
GeneCapture received a prestigious award from the Department of Defense recognizing its advances in rapid pathogen detection.
$2.1 Million DoD Contract
GeneCapture secured a $2.1 million contract from the Department of Defense to prepare its portable rapid pathogen detection technology for field testing.
Defense Health Agency Contract
GeneCapture was awarded a contract to develop wound pathogen detection and antibiotic susceptibility testing for the Defense Health Agency.
$2.5 Million DoD Award
GeneCapture was awarded a $2.5 million contract from the Department of Defense for developing rapid pathogen detection and antibiotic susceptibility testing platform for military and civilian use.
$1 Million DoD Award
GeneCapture received a $1 million award to add invasive fungal pathogen probes to its rapid detection panel, supporting military and civilian health.
Collaboration with Auburn University
GeneCapture announced a collaboration with Auburn University to enable remote infection detection for animal and agricultural applications, supported by a SBIR grant.
National DoD Award
GeneCapture received a prestigious award from the Department of Defense recognizing its advances in rapid pathogen detection.
$2.1 Million DoD Contract
GeneCapture secured a $2.1 million contract from the Department of Defense to prepare its portable rapid pathogen detection technology for field testing.
Defense Health Agency Contract
GeneCapture was awarded a contract to develop wound pathogen detection and antibiotic susceptibility testing for the Defense Health Agency.